| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.087 | 0.08 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |